Cargando…
CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis
BACKGROUND: Prostate cancer is one of the most common non-cutaneous malignancies in men. We aimed to systemically evaluate the relationship between the expression of CD147 in tissues and the clinicopathological features of prostate cancer. METHODS AND FINDINGS: PubMed (1966–2016), EMBASE (1980–2016)...
Autores principales: | Peng, Fei, Li, Hui, Ning, Zhaoze, Yang, Zhenyu, Li, Hongru, Wang, Yonggang, Chen, Fang, Wu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042541/ https://www.ncbi.nlm.nih.gov/pubmed/27684938 http://dx.doi.org/10.1371/journal.pone.0163678 |
Ejemplares similares
-
CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Peng, Fei, et al.
Publicado: (2017) -
The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
por: Ye, Yun, et al.
Publicado: (2016) -
CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis
por: Li, Hongru, et al.
Publicado: (2017) -
CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
por: Xin, Xiaoyan, et al.
Publicado: (2016) -
The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis
por: Li, Hui, et al.
Publicado: (2017)